ASA Connect

The Ingram Olkin Forum Series: Unplanned Clinical Trial Disruptions. We do not want you to miss this important event tomorrow/Tuesday.!
Session Five: Coping with Information Loss and the Use of Auxiliary Sources of Data
March 23, 2021 10 am - 1 pm ET, Tuesday

Session Five continues an Ingram Olkin Forum series that started with views from statistics leadership in US NIH and regulatory agencies. Following these introductory sessions, we focus on particular statistical methodologies that might contribute to statistical responses to unplanned clinical trial disruptions or provided a basis for the development of methods that provide a more appropriate response to this challenge. Topic specific sessions to date include Estimands and Missing Data and Randomization Tests. We are pleased to announce Session Five (Please click on the preceding links to catch up with this series).

Session Five Agenda Highlights
Speakers
Nigel Stallard, (Warwick Medical School)
"Using short term endpoint data in interrupted clinical trials"
Marc Vandemeulebroecke, (Novartis)
"Mitigating "force majeure" trial disruptions by leveraging external data, with special reference to pooling approaches"
Heng Li, (FDA, NIH)
"Mitigating study power loss in disrupted clinical trials: Leveraging external data via propensity score-integrated approaches"

Speakers Followed by Break-out Room Discussions.

Session Five registration is $25. There is no fee if you were on the program of an earlier session in this series, previously paid for the series ($75), you belong to a NISS affiliate (https://www.niss.org/affiliates-list), or you are a graduate student less than 6 years post Ph.D. If any of these cases apply - please send an email to officeadmin@niss.org.

Register for this Event Now!









------------------------------
Randy Freret
Sr. Executive Assistant/Administrator
NISS
------------------------------